Furthermore, we used complex statistical methods to analyze the RBPs related to the prognosis of ccRCC patients and finally obtained 9 RBPs, namely, RPL36A, THOC6, RNASE2, U2AF1L4, TLR3, PPARGC1A, DARS, LARS2, and NOVA2, most of which have been reported in detail in terms of the roles in kidney cancer and other tumors. This evidence concerns the gene NOVA2 and nonpapillary renal cell carcinoma.